Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 5067-5072, November 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thompson, H.
Right arrow Articles by Ip, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thompson, H.
Right arrow Articles by Ip, C.

Morphological and Biochemical Status of the Mammary Gland as Influenced by Conjugated Linoleic Acid: Implication for a Reduction in Mammary Cancer Risk1

Henry Thompson, Zongjian Zhu, Sebastiano Banni, Kathleen Darcy, Tami Loftus and Clement Ip2

Division of Laboratory Research, AMC Cancer Research Center, Denver, Colorado 80214 [H. T., Z. Z.]; Dipartimento di Biologia Sperimentale, Sezione di Patologia Sperimentale, Universita'degli Studi di Cagliari, 09124 Cagliari, Italy [S. B.]; and Department of Experimental Therapeutics, Grace Cancer Drug Center [K. D.], and Department of Surgical Oncology [T. L., C. I.], Roswell Park Cancer Institute, Buffalo, New York 14263

Previous research showed that treatment with conjugated linoleic acid (CLA) during the period of active mammary gland morphogenesis was sufficient to confer a lasting protection against subsequent mammary tumorigenesis induced by methylnitrosourea. The present study was designed to characterize certain morphological and biochemical changes of the mammary gland that might potentially render it less susceptible to cancer induction. Female Sprague Dawley rats were fed a 1% CLA diet from weaning until about 50 days of age. The mammary gland parameters under investigation included (a) the deposition of neutral lipid, (b) the identification and quantification of CLA and its metabolites, (c) the density of the epithelium, and (d) the proliferative activity of various structural components. Our results showed that CLA treatment did not affect total fat deposition in the mammary tissue nor the extent of epithelial invasion into the surrounding fat pad but was able to cause a 20% reduction in the density of the ductal-lobular tree as determined by digitized image analysis of the whole mounts. This was accompanied by a suppression of bromodeoxyuridine labeling in the terminal end buds and lobuloalveolar buds. The recovery of desaturation and elongation products of CLA in the mammary gland confirmed our prior suggestion that the metabolism of CLA might be critical to risk modulation. The significance of the above findings was investigated in a mammary carcinogenesis bioassay with the use of the dimethylbenz[a]anthracene model. When CLA was started at weaning and continued for 6 months until the end of the experiment, this schedule of supplementation produced essentially the same magnitude of mammary tumor inhibition in the dimethylbenz[a]anthracene model as that produced by 1 month of CLA feeding from weaning. The observation is consistent with the hypothesis that exposure to CLA during the time of mammary gland maturation may modify the developmental potential of a subset of target cells that are normally susceptible to carcinogen-induced transformation.

1 This work was supported by National Cancer Institute Grant CA 61763 (to C. I.) and Department of the Army Grant DAMD 17-94-J-A274 (to H. T.).

2 To whom requests for reprints should be addressed, at Department of Surgical Oncology, Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY 14263.

Received 5/30/97. Accepted 9/19/97.




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
L. Ou, Y. Wu, C. Ip, X. Meng, Y.-C. Hsu, and M. M. Ip
Apoptosis induced by t10,c12-conjugated linoleic acid is mediated by an atypical endoplasmic reticulum stress response
J. Lipid Res., May 1, 2008; 49(5): 985 - 994.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
X. Meng, S. F. Shoemaker, S. O. McGee, and M. M. Ip
t10,c12-Conjugated linoleic acid stimulates mammary tumor progression in Her2/ErbB2 mice through activation of both proliferative and survival pathways
Carcinogenesis, May 1, 2008; 29(5): 1013 - 1021.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. M. Ip, S. O. McGee, P. A. Masso-Welch, C. Ip, X. Meng, L. Ou, and S. F. Shoemaker
The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium
Carcinogenesis, June 1, 2007; 28(6): 1269 - 1276.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
N. E. Hubbard, D. Lim, and K. L. Erickson
Conjugated Linoleic Acid Alters Matrix Metalloproteinases of Metastatic Mouse Mammary Tumor Cells
J. Nutr., June 1, 2007; 137(6): 1423 - 1429.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
C. Rodriguez-Sallaberry, C. Caldari-Torres, E. S. Greene, and L. Badinga
Conjugated Linoleic Acid Reduces Phorbol Ester-Induced Prostaglandin F2{alpha} Production by Bovine Endometrial Cells.
J Dairy Sci, October 1, 2006; 89(10): 3826 - 3832.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
L. Badinga and E. S. Greene
Physiological Properties of Conjugated Linoleic Acid and Implications for Human Health
Nutr Clin Pract, August 1, 2006; 21(4): 367 - 373.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. E. McCann, C. Ip, M. M. Ip, M. K. McGuire, P. Muti, S. B. Edge, M. Trevisan, and J. L. Freudenheim
Dietary Intake of Conjugated Linoleic Acids and Risk of Premenopausal and Postmenopausal Breast Cancer, Western New York Exposures and Breast Cancer Study (WEB Study)
Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1480 - 1484.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. J Field and P. D Schley
Evidence for potential mechanisms for the effect of conjugated linoleic acid on tumor metabolism and immune function: lessons from n-3 fatty acids
Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1190S - 1198S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. Degrace, L. Demizieux, J. Gresti, J.-M. Chardigny, J.-L. Sebedio, and P. Clouet
Hepatic Steatosis Is Not Due to Impaired Fatty Acid Oxidation Capacities in C57BL/6J Mice Fed the Conjugated trans-10,cis-12-Isomer of Linoleic Acid
J. Nutr., April 1, 2004; 134(4): 861 - 867.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. A. Masso-Welch, D. Zangani, C. Ip, M. M. Vaughan, S. F. Shoemaker, S. O. McGee, and M. M. Ip
Isomers of Conjugated Linoleic Acid Differ in Their Effects on Angiogenesis and Survival of Mouse Mammary Adipose Vasculature
J. Nutr., February 1, 2004; 134(2): 299 - 307.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
T. M. Larsen, S. Toubro, and A. Astrup
Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies
J. Lipid Res., December 1, 2003; 44(12): 2234 - 2241.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Q. Kemp, B. D. Jeffy, and D. F. Romagnolo
Conjugated Linoleic Acid Inhibits Cell Proliferation through a p53-Dependent Mechanism: Effects on the Expression of G1-Restriction Points in Breast and Colon Cancer Cells
J. Nutr., November 1, 2003; 133(11): 3670 - 3677.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. A. Belury
Inhibition of Carcinogenesis by Conjugated Linoleic Acid: Potential Mechanisms of Action
J. Nutr., October 1, 2002; 132(10): 2995 - 2998.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. A. Masso-Welch, D. Zangani, C. Ip, M. M. Vaughan, S. Shoemaker, R. A. Ramirez, and M. M. Ip
Inhibition of Angiogenesis by the Cancer Chemopreventive Agent Conjugated Linoleic Acid
Cancer Res., August 1, 2002; 62(15): 4383 - 4389.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
V. Chajes, F. Lavillonniere, P. Ferrari, M.-L. Jourdan, M. Pinault, V. Maillard, J.-L. Sebedio, and P. Bougnoux
Conjugated Linoleic Acid Content in Breast Adipose Tissue Is Not Associated with the Relative Risk of Breast Cancer in a Population of French Patients
Cancer Epidemiol. Biomarkers Prev., July 1, 2002; 11(7): 672 - 673.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Ip, M. M. Ip, T. Loftus, S. Shoemaker, and W. Shea-Eaton
Induction of Apoptosis by Conjugated Linoleic Acid in Cultured Mammary Tumor Cells and Premalignant Lesions of the Rat Mammary Gland
Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 689 - 696.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
C. Ip, S. Banni, E. Angioni, G. Carta, J. McGinley, H. J. Thompson, D. Barbano, and D. Bauman
Conjugated Linoleic Acid-Enriched Butter Fat Alters Mammary Gland Morphogenesis and Reduces Cancer Risk in Rats
J. Nutr., December 1, 1999; 129(12): 2135 - 2142.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
B. Kamlage, L. Hartmann, B. Gruhl, and M. Blaut
Intestinal Microorganisms Do Not Supply Associated Gnotobiotic Rats with Conjugated Linoleic Acid
J. Nutr., December 1, 1999; 129(12): 2212 - 2217.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
S. T. Franklin, K. R. Martin, R. J. Baer, D. J. Schingoethe, and A. R. Hippen
Dietary Marine Algae (Schizochytrium sp.) Increases Concentrations of Conjugated Linoleic, Docosahexaenoic and Transvaccenic Acids in Milk of Dairy Cows
J. Nutr., November 1, 1999; 129(11): 2048 - 2054.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
S. Banni, E. Angioni, V. Casu, M. P. Melis, G. Carta, F. P. Corongiu, H. Thompson, and C. Ip
Decrease in linoleic acid metabolites as a potential mechanism in cancer risk reduction by conjugated linoleic acid
Carcinogenesis, June 1, 1999; 20(6): 1019 - 1024.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.